Heart Transplant Market is expected to reach US$ 35,470.84 million by 2030

Hospital Segment to Hold Significant Share of Heart Transplant Market During 2022–2030  

According to our latest study on "Heart Transplant Market Forecast to 2030 – Global Analysis – Surgery Type, Type, and End User," the heart transplant market value is expected to reach US$ 35,470.84 million by 2030 from US$ 15,472.79 million in 2022. The report emphasizes the key factors driving the market and prominent players with their developments. The increasing target disease incidence and growing geriatric population are the key factors driving the market development. However, the high cost of surgeries hampers the heart transplant market growth.

Hospitals are large entities that have multiple facilities available in a single organization. Hospitals also provide various diagnostics and treatment facilities that can be reimbursed under insurance claims. They employ various doctors, specialists’, and other healthcare professionals to provide better healthcare services. All cardiovascular diseases can be treated in hospitals, and they provide improved nursing services. 

To get free sample copy of the report, along with the TOC, Statistics, and Tables please visit @ https://www.theinsightpartners.com/sample/TIPRE00012146

A high prevalence of conventional CVD risk factors (e.g., diabetes, hypertension, dyslipidemia) can be associated with an increasing need for heart transplant procedures. In 2020, nearly 8,200 heart transplants were performed worldwide, out of which, 3,658 were performed in the US. Heart transplantation is a highly complex surgery, and hence, these procedures are performed at the most well-equipped hospitals. There are fewer than 150 hospitals in the US (out of more than 6,000 hospitals) that perform heart transplant surgeries. The survival rate is good with appropriate follow-up care with healthcare professionals from hospital staff.

Heart Transplant Market, by Surgery Type:

The heart transplant market, by surgery type, is segmented into orthotopic heart transplantation and heterotopic heart transplantation. The orthotopic heart transplant segment held a larger market share in 2022 and is projected to register a higher CAGR during the forecast period (2022-2030). An orthotopic heart transplant is the most commonly utilized technique. In the orthotopic approach, the recipient's heart is removed and the donor’s heart is used to restore it in the correct anatomical position. After the donor’s heart is removed, it is preserved and packed for transport, and it must be transplanted into the receiver within 4–5 hours. While the heart transplant is being performed, general anesthesia is given to the receiver and is arranged on a bypass machine to oxygenate the blood.

Heart Transplant Market, by Type:

The heart transplant market, by type, is segmented into donor live heart and artificial heart. The donor live heart segment held a larger market share in 2022. The artificial heart segment is anticipated to register a higher CAGR during the forecast period (2022-2023). A living-donor transplant is an operating procedure to remove heart from a dead person and place it in another person whose heart is no longer functioning properly. The popularity of living-organ donation has increased significantly in recent years due to the burgeoning need for organs for transplantation and the shortage of hearts from deceased persons (obtained via voluntary donation). Most donors are declared dead after tests that determine brain death. Although they are kept on a ventilator as they can’t breathe for themselves, their heart continues to beat. Traditionally, all transplanted hearts have come from living donors in the last 40 years.

Heart Transplant Market, by Geography:

Based on geography, the heart transplant market is primarily divided into North America (US, Canada, and Mexico), Europe (Spain, UK, Germany, France, Italy, and Rest of Europe), Asia Pacific (South Korea, China, India, Japan, Australia, and Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, UAE, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).

Terumo Corp, LivaNova Plc, Jarvik Heart Inc, BiVACOR Inc, Evaheart Inc, Berlin Heart GmbH, BioVentrix, SynCardia Systems LLC, Calon Cardio-Technology Ltd, and Abbott Laboratories are the prominent heart transplant market players.

Contact Us
Contact Us: The Insight Partners 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com